Skip to main content
Premium Trial:

Request an Annual Quote

Luminex, Northrop Grumman Partner on Biodetection

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex and Northrop Grumman will collaborate to develop biodetector systems that can continuously monitor the environment and serve as an early warning system for dangerous airborne pathogens, Luminex said today.

The multiplexed system, which is being developed for evaluation by the US government as part of a national network of automated environmental monitoring devices, will be based on Luminex's xMAP technology.

The xMAP technology will enable biodetectors to run many simultaneous tests on a single sample, the company said.

"When it comes to environmental detection of biological pathogens, fast and accurate answers are essential, David Tilles, VP of CBRNE Defense at Northrop Grumman's Advanced Concepts and Technologies Division, said in a statement.

Tilles said that the xMAP "gives us a cost-effective, flexible capability that can quickly and accurately detect multiple biohazards at once."

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more